These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 33597243)
1. Repression of Wnt/β-catenin signaling by SOX9 and Mastermind-like transcriptional coactivator 2. Sinha A; Fan VB; Ramakrishnan AB; Engelhardt N; Kennell J; Cadigan KM Sci Adv; 2021 Feb; 7(8):. PubMed ID: 33597243 [TBL] [Abstract][Full Text] [Related]
2. SOX9 and TCF transcription factors associate to mediate Wnt/β-catenin target gene activation in colorectal cancer. Ramakrishnan AB; Burby PE; Adiga K; Cadigan KM J Biol Chem; 2023 Jan; 299(1):102735. PubMed ID: 36423688 [TBL] [Abstract][Full Text] [Related]
3. SOX9/NFIA promotes human ovarian cancer metastasis through the Wnt/β-catenin signaling pathway. Lu R; Tang P; Zhang D; Lin S; Li H; Feng X; Sun M; Zhang H Pathol Res Pract; 2023 Aug; 248():154602. PubMed ID: 37315400 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of SOX9 promotes the self-renewal and tumorigenicity of cervical cancer through activating the Wnt/β-catenin signaling pathway. Feng Q; Cui N; Li S; Cao J; Chen Q; Wang H FASEB J; 2023 Oct; 37(10):e23174. PubMed ID: 37668416 [TBL] [Abstract][Full Text] [Related]
5. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer. Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204 [TBL] [Abstract][Full Text] [Related]
6. SOX9 regulated proliferation and apoptosis of human lung carcinoma cells by the Wnt/β-catenin signaling pathway. Guo YZ; Xie XL; Fu J; Xing GL Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4898-4907. PubMed ID: 30070325 [TBL] [Abstract][Full Text] [Related]
7. Sox9 inhibits Wnt signaling by promoting beta-catenin phosphorylation in the nucleus. Topol L; Chen W; Song H; Day TF; Yang Y J Biol Chem; 2009 Jan; 284(5):3323-3333. PubMed ID: 19047045 [TBL] [Abstract][Full Text] [Related]
8. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway. Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551 [TBL] [Abstract][Full Text] [Related]
9. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. Alves-Guerra MC; Ronchini C; Capobianco AJ Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709 [TBL] [Abstract][Full Text] [Related]
10. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin. Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200 [TBL] [Abstract][Full Text] [Related]
11. SOX9 Overexpression Promotes Glioma Metastasis via Wnt/β-Catenin Signaling. Liu H; Liu Z; Jiang B; Peng R; Ma Z; Lu J Cell Biochem Biophys; 2015 Sep; 73(1):205-12. PubMed ID: 25716338 [TBL] [Abstract][Full Text] [Related]
12. Wnt signaling in ovarian development inhibits Sf1 activation of Sox9 via the Tesco enhancer. Bernard P; Ryan J; Sim H; Czech DP; Sinclair AH; Koopman P; Harley VR Endocrinology; 2012 Feb; 153(2):901-12. PubMed ID: 22128028 [TBL] [Abstract][Full Text] [Related]
13. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Jin EJ; Lee SY; Choi YA; Jung JC; Bang OS; Kang SS Mol Cells; 2006 Dec; 22(3):353-9. PubMed ID: 17202865 [TBL] [Abstract][Full Text] [Related]
14. Loss of β-catenin promotes chondrogenic differentiation of aortic valve interstitial cells. Fang M; Alfieri CM; Hulin A; Conway SJ; Yutzey KE Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2601-8. PubMed ID: 25341799 [TBL] [Abstract][Full Text] [Related]
15. Knockdown of SOX9 alleviates tracheal fibrosis through the Wnt/β-catenin signaling pathway. Gu L; Li A; Lin J; Gan Y; He C; Xiao R; Liao J; Li Y; Guo S J Mol Med (Berl); 2022 Nov; 100(11):1659-1670. PubMed ID: 36192639 [TBL] [Abstract][Full Text] [Related]
16. LRP6 transduces a canonical Wnt signal independently of Axin degradation by inhibiting GSK3's phosphorylation of beta-catenin. Cselenyi CS; Jernigan KK; Tahinci E; Thorne CA; Lee LA; Lee E Proc Natl Acad Sci U S A; 2008 Jun; 105(23):8032-7. PubMed ID: 18509060 [TBL] [Abstract][Full Text] [Related]
17. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Li VS; Ng SS; Boersema PJ; Low TY; Karthaus WR; Gerlach JP; Mohammed S; Heck AJ; Maurice MM; Mahmoudi T; Clevers H Cell; 2012 Jun; 149(6):1245-56. PubMed ID: 22682247 [TBL] [Abstract][Full Text] [Related]
18. SOX9 is an atypical intestinal tumor suppressor controlling the oncogenic Wnt/ß-catenin signaling. Prévostel C; Rammah-Bouazza C; Trauchessec H; Canterel-Thouennon L; Busson M; Ychou M; Blache P Oncotarget; 2016 Dec; 7(50):82228-82243. PubMed ID: 27429045 [TBL] [Abstract][Full Text] [Related]
19. Centrosomes are required for proper β-catenin processing and Wnt response. Vora SM; Fassler JS; Phillips BT Mol Biol Cell; 2020 Aug; 31(17):1951-1961. PubMed ID: 32583737 [TBL] [Abstract][Full Text] [Related]
20. Identification of targets of the Wnt pathway destruction complex in addition to beta-catenin. Kim NG; Xu C; Gumbiner BM Proc Natl Acad Sci U S A; 2009 Mar; 106(13):5165-70. PubMed ID: 19289839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]